Skip to Main Content

Amit N. Vora, MD, MPH, FACC, FSCAI

Assistant Professor of Medicine (Cardiovascular Medicine)
DownloadHi-Res Photo

About

Titles

Assistant Professor of Medicine (Cardiovascular Medicine)

Biography

Amit N. Vora MD, MPH, graduated from Johns Hopkins School of Medicine and did his residency training at Brigham and Women's Hospital. He then completed his cardiology training, which included additional training in interventional cardiology and structural heart disease, at Duke University Medical Center. He joins us after almost five years at the UPMC Heart and Vascular Institute in Harrisburg, PA where he served as the Associate Medical Director of the Structural Heart Program and Vice Chair of Structural Heart Research. He has extensive clinical expertise in catheter-based interventional and structural heart interventions, including transcatheter aortic valve replacement, transcatheter mitral/tricuspid valve therapies, and left atrial appendage occlusion. His research interests include antithrombotic therapy selection following PCI and minimizing conduction system abnormalities following transcatheter aortic valve replacement.

Appointments

Other Departments & Organizations

Education & Training

MPH
Harvard School of Public Health, Quantitative Methods
MD
Johns Hopkins University School of Medicine
BS
Johns Hopkins University, Biology

Research

Overview

Medical Subject Headings (MeSH)

Cardiology

Clinical Care

Overview

Amit N. Vora MD, MPH, is an interventional cardiologist and director of the Transcatheter Mitral Valve Program. He specializes in structural heart disease, which includes defects and disorders of the heart’s chambers, muscles, valves, and walls.

As an interventionalist, Dr. Vora performs catheter-based procedures that include complex coronary repairs and the placement of stents, offering many patients who otherwise might have had open heart surgery a minimally invasive procedure with a much quicker recovery. Additionally, he has particular expertise in transcatheter aortic valve replacement (TAVR), MitraClip, and Watchman left atrial appendage occlusion (for patients with atrial fibrillation that are not candidates for long-term blood thinners).

“What I like most about interventional cardiology—and specifically structural heart disease—is that it includes therapies that not only help people feel better, but also live longer,” Dr. Vora says. “We have therapies now that weren’t available even five years ago—and five or 10 years from now we expect the transcatheter approaches we’ll be able to offer to be far beyond what we can even imagine right now.”

Currently improvements in technology are making it possible to streamline procedures and offer innovations that include catheter-based heart valves in their third or fourth generation, he adds.

An assistant professor of cardiovascular medicine at Yale School of Medicine, Dr. Vora is also a researcher who has most recently worked on clinical trials to refine a mesh-like device used to protect major blood vessels during transcatheter aortic valve replacement (TAVR). He says the device could prevent rare instances of stroke during the procedure.

Board Certifications

  • Interventional Cardiology

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    2017
  • Cardiovascular Disease

    Certification Organization
    AB of Internal Medicine
    Original Certification Date
    2015

Yale Medicine News

Get In Touch

Contacts